CCP
NXTM

Clough Capital Partners’s NxStage Medical Inc. NXTM Stock Holding History

Clough Capital Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-136,900
Closed -$3.82M – 164
2018
Q2 		$3.82M Sell
136,900
-64,700
-32% -$1.73M 0.34% 70
2018
Q1 		$5.01M Sell
201,600
-4,300
-2% -$105K 0.48% 60
2017
Q4 		$4.99M Buy
+205,900
New +$5.42M 0.42% 66
2017
Q3 		– Sell
-271,500
Closed -$6.81M – 154
2017
Q2 		$6.81M Buy
271,500
+59,200
+28% +$1.47M 0.47% 55
2017
Q1 		$5.7M Buy
212,300
+192,000
+946% +$5.3M 0.36% 69
2016
Q4 		$532K Buy
+20,300
New +$502K 0.04% 144
2015
Q3 		– Sell
-186,300
Closed -$2.66M – 238
2015
Q2 		$2.66M Buy
+186,300
New +$3.16M 0.1% 130
2014
Q4 		– Sell
-197,416
Closed -$2.59M – 226
2014
Q3 		$2.59M Sell
197,416
-8,300
-4% -$112K 0.1% 138
2014
Q2 		$2.96M Buy
205,716
+13,403
+7% +$175K 0.09% 148
2014
Q1 		$2.45M Sell
192,313
-466,700
-71% -$6.09M 0.08% 151
2013
Q4 		$6.59M Sell
659,013
-92,387
-12% -$1.05M 0.22% 126
2013
Q3 		$9.89M Buy
751,400
+180,200
+32% +$2.36M 0.31% 119
2013
Q2 		$8.16M Buy
+571,200
New +$7.18M 0.27% 120

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Clough Capital Partners's NXTM Position: Q3 2018 in Review

Clough Capital Partners sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 136,900 shares — an estimated $3.82M sold.

Clough Capital Partners first reported a position in NXTM in Q2 2013 and held it in 13 quarters. The position peaked at $9.89M in Q3 2013. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Clough Capital Partners reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • Clough Capital Partners sold 136,900 NxStage Medical Inc. shares in Q3 2018, an estimated $3.82M.
  • Clough Capital Partners first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 13 quarters.
  • Clough Capital Partners's NxStage Medical Inc. position peaked at $9.89M in Q3 2013.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Clough Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.